- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 11 results
In the News · Source: The Wall Street Journal, HBW Insight and Pink Sheet
In the News · Source: WBUR On Point
Recognition
February 7, 2023
King & Spalding Lawyers Named to Leadership Council on Legal Diversity Fellowship, Pathfinder Programs
In the News · Source: Mealey's Daily News Update - PI/Product Liability
February 1, 2023
Andy Bayman, TaCara Harris, Meredith Redwine and Aaron Parks counsel GSK in a Paxil birth defect case before a Delaware state court
In the News · Source: The Wall Street Journal, The New York Times, ABC News, Law360, Politico, Bloomberg Law and Ms. Magazine
In the News · Source: Pink Sheet
In the News · Source: Law360
November 9, 2022
Val Leppert and Heather Howard counsel Coloplast before the Eleventh Circuit, which refused to revive claims against the company in a pelvic mesh dispute
In the News · Source: Law360
July 19, 2022
Aaron Parks obtains a successful summary judgment motion on behalf of Coloplast before a Minnesota federal court
Recognition
March 1, 2022
Melvin Bailey Inducted Into American College of Trial Lawyers
Press Release
January 26, 2021
Top Healthcare Partner Richard Zall Joins King & Spalding in New York